290 related articles for article (PubMed ID: 32871892)
41. Systematic review and meta-analysis of the clinical outcomes of ACEI/ARB in East-Asian patients with COVID-19.
Huang NX; Yuan Q; Fang F; Yan BP; Sanderson JE
PLoS One; 2023; 18(1):e0280280. PubMed ID: 36634085
[TBL] [Abstract][Full Text] [Related]
42. Effects of respiratory rehabilitation on patients with novel coronavirus (COVID-19) pneumonia in the rehabilitation phase: protocol for a systematic review and meta-analysis.
Zhu F; Zhang M; Gao M; Zeng C; Wang D; Hong Q; Chen W
BMJ Open; 2020 Jul; 10(7):e039771. PubMed ID: 32665352
[TBL] [Abstract][Full Text] [Related]
43. Chinese medicine treatment of mastitis in COVID-19 patients: A protocol for systematic review.
Wen D; Shi Y; Zhang X; Lv G
Medicine (Baltimore); 2020 Aug; 99(35):e21656. PubMed ID: 32871880
[TBL] [Abstract][Full Text] [Related]
44. The efficacy and safety of Jinhua Qinggan granule (JHQG) in the treatment of coronavirus disease 2019 (COVID-19): A protocol for systematic review and meta analysis.
Zhang Q; Cao F; Wang Y; Xu X; Sun Y; Li J; Qi X; Sun S; Ji G; Song B
Medicine (Baltimore); 2020 Jun; 99(24):e20531. PubMed ID: 32541475
[TBL] [Abstract][Full Text] [Related]
45. Effect of respiratory rehabilitation training on elderly patients with COVID-19: A protocol for systematic review and meta-analysis.
Yan H; Ouyang Y; Wang L; Luo X; Zhan Q
Medicine (Baltimore); 2020 Sep; 99(37):e22109. PubMed ID: 32925755
[TBL] [Abstract][Full Text] [Related]
46. Favipiravir for treating patients with novel coronavirus (COVID-19): protocol for a systematic review and meta-analysis of randomised clinical trials.
Arab-Zozani M; Hassanipour S; Ghoddoosi-Nejad D
BMJ Open; 2020 Jul; 10(7):e039730. PubMed ID: 32737100
[TBL] [Abstract][Full Text] [Related]
47. Prognosis of COVID-19 in patients with breast cancer: A protocol for systematic review and meta-analysis.
Sheng Z; Zhang L; Liu X; Yuan L; Li F; Dai D; Wu S; Yang J
Medicine (Baltimore); 2020 Jul; 99(31):e21487. PubMed ID: 32756178
[TBL] [Abstract][Full Text] [Related]
48. Diabetes mellitus and COVID-19: A review and management guidance for South Africa.
Coetzee A; Taljaard JJ; Hugo SS; Conradie M; Conradie-Smit M; Dave JA
S Afr Med J; 2020 Jun; 110(8):761-766. PubMed ID: 32880304
[TBL] [Abstract][Full Text] [Related]
49. The effectiveness and safety of traditional Chinese medicine for the treatment of children with COVID-19.
Li Y; Bi L; Li Y; Hu X; Wang Q; Liang X; Yu X; Dong L; Xie Q
Medicine (Baltimore); 2020 Jul; 99(30):e21247. PubMed ID: 32791699
[TBL] [Abstract][Full Text] [Related]
50. Efficacy and safety of Chinese patent medicine injection for COVID-19: A protocol for systematic review and meta-analysis.
Lu M; Lu Z; Zhang T; Wang W; Xue Y; Cao Z
Medicine (Baltimore); 2020 Jun; 99(25):e20706. PubMed ID: 32569204
[TBL] [Abstract][Full Text] [Related]
51. The therapeutic efficacy of Huashi Baidu Formula combined with antiviral drugs in the treatment of COVID-19: A protocol for systematic review and meta-analysis.
Han L; Wang Y; Hu K; Tang Z; Song X
Medicine (Baltimore); 2020 Oct; 99(42):e22715. PubMed ID: 33080725
[TBL] [Abstract][Full Text] [Related]
52. Angiotensin-converting enzyme inhibitors, angiotensin receptor blockers and combined therapy in patients with micro- and macroalbuminuria and other cardiovascular risk factors: a systematic review of randomized controlled trials.
Maione A; Navaneethan SD; Graziano G; Mitchell R; Johnson D; Mann JF; Gao P; Craig JC; Tognoni G; Perkovic V; Nicolucci A; De Cosmo S; Sasso A; Lamacchia O; Cignarelli M; Manfreda VM; Gentile G; Strippoli GF
Nephrol Dial Transplant; 2011 Sep; 26(9):2827-47. PubMed ID: 21372254
[TBL] [Abstract][Full Text] [Related]
53. Impact of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Hypertensive Patients with COVID-19 (COVIDECA Study).
Mustafic H; Fayssoil A; Josseran L; Ouadahi M; Grimaldi-Bensouda L; Dubourg O; Annane D; Mansencal N
Am J Cardiol; 2021 May; 147():58-60. PubMed ID: 33617818
[TBL] [Abstract][Full Text] [Related]
54. Angiotensin Converting Enzyme Inhibitor and Angiotensin II Receptor Blocker Use Among Outpatients Diagnosed With COVID-19.
Bae DJ; Tehrani DM; Rabadia SV; Frost M; Parikh RV; Calfon-Press M; Aksoy O; Umar S; Ardehali R; Rabbani A; Bokhoor P; Nsair A; Currier J; Tobis J; Fonarow GC; Dave R; Rafique AM
Am J Cardiol; 2020 Oct; 132():150-157. PubMed ID: 32819683
[TBL] [Abstract][Full Text] [Related]
55. Association of Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Testing Positive for Coronavirus Disease 2019 (COVID-19).
Mehta N; Kalra A; Nowacki AS; Anjewierden S; Han Z; Bhat P; Carmona-Rubio AE; Jacob M; Procop GW; Harrington S; Milinovich A; Svensson LG; Jehi L; Young JB; Chung MK
JAMA Cardiol; 2020 Sep; 5(9):1020-1026. PubMed ID: 32936273
[TBL] [Abstract][Full Text] [Related]
56. The effects of exercise on COVID-19 therapeutics: A protocol for systematic review and meta-analysis.
Xu Z; Chen Y; Yu D; Mao D; Wang T; Feng D; Li T; Yan S; Yu Y
Medicine (Baltimore); 2020 Sep; 99(38):e22345. PubMed ID: 32957405
[TBL] [Abstract][Full Text] [Related]
57. The effect of acupuncture on the quality of life of patients recovering from COVID-19: A systematic review protocol.
Wen D; Wu L; Dong Y; Huang J; Ren K; Jiang J; Dai S; Zhao W; Xu X; Peng D
Medicine (Baltimore); 2020 Jul; 99(30):e20780. PubMed ID: 32791668
[TBL] [Abstract][Full Text] [Related]
58. The efficacy of angiotensin converting enzyme inhibitors versus angiotensin II receptor blockers on insulin resistance in hypertensive patients: A protocol for a systematic review and meta-analysis.
Yao J; Gong X; Shi X; Fan S; Chen J; Chen Q
Medicine (Baltimore); 2020 Jun; 99(24):e20674. PubMed ID: 32541513
[TBL] [Abstract][Full Text] [Related]
59. Association between ABO blood groups and risk of coronavirus disease 2019: A protocol for systematic review and meta-analysis.
Liu N; Zhang T; Ma L; Wang H; Li H
Medicine (Baltimore); 2020 Aug; 99(33):e21709. PubMed ID: 32872048
[TBL] [Abstract][Full Text] [Related]
60. Use of angiotensin converting enzyme inhibitors and angiotensin receptor blockers associated with lower risk of COVID-19 in household contacts.
Armstrong K; Soltoff A; Rieu-Werden M; Metlay J; Haas J
PLoS One; 2021; 16(3):e0247548. PubMed ID: 33651840
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
